Business Overview

EME leverages its unique evolutionary molecular engineering platform to support every phase of the drug discovery and biotechnology industries. From rapid acquisition of candidate molecules through contract research to collaborative research and development through partnerships, and reliable technology licensing, EME develops businesses optimized to meet our clients' needs.

Drug Discovery

Antibody drug discovery

We provide strong support for next-generation drug discovery research, from antibody screening to subsequent optimization.

Details

Pharmaceutical Drugs

Diagnostic reagents

Aiming to improve the accuracy of diagnostic agents, we are also searching for the optimal pairing of VHH antibodies. Pairing with existing antibodies is also possible. We will promote the development of innovative diagnostic agents.

Details

Products

Next-generation cell manufacturing solutions

EME provides access to its proprietary high-performance biomolecules and evolutionary molecular engineering platform, giving you the assets to begin development immediately.

Details

Licensing

Various license provision

We offer licenses for various technology platforms based on our proprietary cDNA Display technology and VHH engineering technology.
We offer comprehensive alliance and technology transfer consultations tailored to our partner companies' drug discovery concepts.

Various license provision

EME's technological advantages

Implementing evolutionary molecular engineering into society

All of EME's operations are based on "evolutionary molecular engineering," which mimics the evolution of life in a test tube and selects molecules with desired functions at high throughput.

  1. cDNA display technology: It allows for stable and diverse mapping of genes and proteins, reliably capturing target molecules from a massive library of 10^14 units.
  2. PharmaLogical Library: A unique, structure-based, humanized VHH artificial library. Minimizes development risks in the early stages.
  3. Animal-free: Because it does not involve animal immunity, it can handle toxic antigens. It balances ethical considerations with reproducibility.

We will propose the optimal collaboration plan for you.

We can offer flexible contracts tailored to your needs, taking into account the nature of your target and the phase of your project.

Return to the top of this page
Contact Us
Request